BioMarin Pharmaceutical Inc. (BMRN)
USD 57.85
(-4.0%)
USD 57.85
(-4.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.9 Billion USD | 14.25% |
| 2022 | 1.61 Billion USD | 17.2% |
| 2021 | 1.37 Billion USD | 2.96% |
| 2020 | 1.33 Billion USD | -0.62% |
| 2019 | 1.34 Billion USD | 14.34% |
| 2018 | 1.17 Billion USD | 9.71% |
| 2017 | 1.07 Billion USD | 18.15% |
| 2016 | 907.23 Million USD | 22.95% |
| 2015 | 737.88 Million USD | 18.77% |
| 2014 | 621.27 Million USD | 37.22% |
| 2013 | 452.74 Million USD | 10.72% |
| 2012 | 408.89 Million USD | 14.43% |
| 2011 | 357.33 Million USD | 16.78% |
| 2010 | 305.98 Million USD | 18.26% |
| 2009 | 258.74 Million USD | 6.05% |
| 2008 | 243.98 Million USD | 136.37% |
| 2007 | 103.22 Million USD | 36.77% |
| 2006 | 75.46 Million USD | 227.56% |
| 2005 | 23.04 Million USD | 56.86% |
| 2004 | 14.68 Million USD | 21.39% |
| 2003 | 12.1 Million USD | -13.07% |
| 2002 | 13.91 Million USD | 18.98% |
| 2001 | 11.69 Million USD | -38.23% |
| 2000 | 18.94 Million USD | 44.91% |
| 1999 | 13.07 Million USD | 587.89% |
| 1998 | 1.9 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 545.41 Billion USD | -1.17% |
| 2024 Q1 | 509.35 Million USD | -0.27% |
| 2024 Q2 | 563.9 Million USD | 10.71% |
| 2023 Q4 | 510.72 Million USD | 14.63% |
| 2023 FY | 1.84 Billion USD | 14.25% |
| 2023 Q2 | 450.91 Million USD | 0.05% |
| 2023 Q3 | 445.53 Million USD | -1.19% |
| 2023 Q1 | 450.69 Million USD | 9.86% |
| 2022 Q1 | 402.39 Million USD | 21.92% |
| 2022 Q3 | 389.05 Million USD | -5.26% |
| 2022 Q4 | 410.24 Million USD | 5.45% |
| 2022 FY | 1.61 Billion USD | 17.2% |
| 2022 Q2 | 410.67 Million USD | 2.06% |
| 2021 Q2 | 374.63 Million USD | 2.4% |
| 2021 Q4 | 330.06 Million USD | 8.14% |
| 2021 Q1 | 365.86 Million USD | 12.24% |
| 2021 FY | 1.37 Billion USD | 2.96% |
| 2021 Q3 | 305.2 Million USD | -18.53% |
| 2020 Q2 | 331.51 Million USD | -15.15% |
| 2020 FY | 1.33 Billion USD | -0.62% |
| 2020 Q1 | 390.69 Million USD | 8.97% |
| 2020 Q4 | 325.97 Million USD | 13.19% |
| 2020 Q3 | 287.99 Million USD | -13.13% |
| 2019 Q2 | 310.32 Million USD | -0.4% |
| 2019 Q1 | 311.56 Million USD | 11.99% |
| 2019 Q4 | 358.54 Million USD | -1.54% |
| 2019 FY | 1.34 Billion USD | 14.34% |
| 2019 Q3 | 364.14 Million USD | 17.34% |
| 2018 Q4 | 278.19 Million USD | -11.07% |
| 2018 Q2 | 293.82 Million USD | 0.93% |
| 2018 FY | 1.17 Billion USD | 9.71% |
| 2018 Q3 | 312.81 Million USD | 6.46% |
| 2018 Q1 | 291.11 Million USD | 3.12% |
| 2017 Q3 | 274.66 Million USD | 5.18% |
| 2017 FY | 1.07 Billion USD | 18.15% |
| 2017 Q1 | 253.73 Million USD | 7.54% |
| 2017 Q4 | 282.31 Million USD | 2.78% |
| 2017 Q2 | 261.14 Million USD | 2.92% |
| 2016 FY | 907.23 Million USD | 22.95% |
| 2016 Q4 | 235.94 Million USD | 2.96% |
| 2016 Q3 | 229.15 Million USD | -7.79% |
| 2016 Q2 | 248.51 Million USD | 28.35% |
| 2016 Q1 | 193.61 Million USD | 7.63% |
| 2015 Q2 | 210.64 Million USD | 23.58% |
| 2015 Q4 | 179.89 Million USD | 4.48% |
| 2015 Q3 | 172.18 Million USD | -18.26% |
| 2015 FY | 737.88 Million USD | 18.77% |
| 2015 Q1 | 170.45 Million USD | -7.88% |
| 2014 Q4 | 185.03 Million USD | 25.94% |
| 2014 FY | 621.27 Million USD | 37.22% |
| 2014 Q1 | 128.73 Million USD | 5.3% |
| 2014 Q3 | 146.92 Million USD | -8.5% |
| 2014 Q2 | 160.57 Million USD | 24.73% |
| 2013 Q2 | 114.24 Million USD | 6.34% |
| 2013 Q1 | 107.42 Million USD | 1.92% |
| 2013 Q4 | 122.25 Million USD | 12.34% |
| 2013 FY | 452.74 Million USD | 10.72% |
| 2013 Q3 | 108.82 Million USD | -4.75% |
| 2012 Q3 | 103.49 Million USD | 3.04% |
| 2012 Q4 | 105.4 Million USD | 1.84% |
| 2012 FY | 408.89 Million USD | 14.43% |
| 2012 Q1 | 99.54 Million USD | 15.31% |
| 2012 Q2 | 100.44 Million USD | 0.91% |
| 2011 Q2 | 91.36 Million USD | 3.05% |
| 2011 Q3 | 90.98 Million USD | -0.42% |
| 2011 Q4 | 86.32 Million USD | -5.11% |
| 2011 FY | 357.33 Million USD | 16.78% |
| 2011 Q1 | 88.66 Million USD | 9.26% |
| 2010 Q3 | 79.74 Million USD | 2.83% |
| 2010 Q2 | 77.54 Million USD | 14.82% |
| 2010 Q1 | 67.54 Million USD | -4.0% |
| 2010 FY | 305.98 Million USD | 18.26% |
| 2010 Q4 | 81.14 Million USD | 1.75% |
| 2009 FY | 258.74 Million USD | 6.05% |
| 2009 Q1 | 59.61 Million USD | -31.95% |
| 2009 Q4 | 70.35 Million USD | 6.86% |
| 2009 Q3 | 65.83 Million USD | 4.6% |
| 2009 Q2 | 62.93 Million USD | 5.57% |
| 2008 Q3 | 58.58 Million USD | 7.33% |
| 2008 Q2 | 54.58 Million USD | 26.32% |
| 2008 Q4 | 87.61 Million USD | 49.55% |
| 2008 Q1 | 43.2 Million USD | 9.03% |
| 2008 FY | 243.98 Million USD | 136.37% |
| 2007 Q2 | 24.32 Million USD | 29.94% |
| 2007 FY | 103.22 Million USD | 36.77% |
| 2007 Q1 | 18.72 Million USD | 1.73% |
| 2007 Q4 | 39.63 Million USD | 92.88% |
| 2007 Q3 | 20.54 Million USD | -15.54% |
| 2006 Q1 | 12.09 Million USD | 48.4% |
| 2006 FY | 75.46 Million USD | 227.56% |
| 2006 Q4 | 18.4 Million USD | -17.53% |
| 2006 Q3 | 22.31 Million USD | -1.53% |
| 2006 Q2 | 22.66 Million USD | 87.44% |
| 2005 Q4 | 8.14 Million USD | 9.87% |
| 2005 Q2 | 3.14 Million USD | -27.28% |
| 2005 Q1 | 4.32 Million USD | -59.13% |
| 2005 Q3 | 7.41 Million USD | 135.55% |
| 2005 FY | 23.04 Million USD | 56.86% |
| 2004 FY | 14.68 Million USD | 21.39% |
| 2004 Q3 | 146 Thousand USD | -96.3% |
| 2004 Q4 | 10.59 Million USD | 7154.79% |
| 2004 Q2 | 3.95 Million USD | 0.0% |
| 2004 Q1 | - USD | 100.0% |
| 2003 Q1 | 3.49 Million USD | 11.52% |
| 2003 FY | 12.1 Million USD | -13.07% |
| 2003 Q4 | -15.59 Million USD | 0.0% |
| 2003 Q3 | - USD | -100.0% |
| 2003 Q2 | 12.1 Million USD | 246.11% |
| 2002 Q3 | 3.56 Million USD | 4.27% |
| 2002 Q4 | 3.13 Million USD | -12.16% |
| 2002 FY | 13.91 Million USD | 18.98% |
| 2002 Q1 | 3.79 Million USD | 325.59% |
| 2002 Q2 | 3.42 Million USD | -9.73% |
| 2001 FY | 11.69 Million USD | -38.23% |
| 2001 Q4 | 891 Thousand USD | -74.27% |
| 2001 Q3 | 3.46 Million USD | 3.19% |
| 2001 Q2 | 3.35 Million USD | -33.27% |
| 2001 Q1 | 5.02 Million USD | 1.53% |
| 2000 Q3 | 4.52 Million USD | -2.08% |
| 2000 Q4 | 4.95 Million USD | 9.58% |
| 2000 Q2 | 4.61 Million USD | -4.84% |
| 2000 Q1 | 4.85 Million USD | 8.52% |
| 2000 FY | 18.94 Million USD | 44.91% |
| 1999 FY | 13.07 Million USD | 587.89% |
| 1999 Q2 | 2.7 Million USD | -12.9% |
| 1999 Q3 | 3.9 Million USD | 44.44% |
| 1999 Q1 | 3.1 Million USD | 0.0% |
| 1999 Q4 | 4.47 Million USD | 14.62% |
| 1998 FY | 1.9 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -4908.21% |
| Alkermes plc | 1.37 Billion USD | -38.532% |
| Agenus Inc. | 139.61 Million USD | -1264.017% |
| Aptorum Group Limited | -1.11 Million USD | 170943.501% |
| Ardelyx, Inc. | 106.66 Million USD | -1685.444% |
| Dyadic International, Inc. | 922.95 Thousand USD | -206233.773% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -8942.173% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1089289.73% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 14356.578% |
| Novavax, Inc. | 639.93 Million USD | -197.587% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 4165.783% |
| Pyxis Oncology, Inc. | -2 Million USD | 95318.6% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 368631.542% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -9900.378% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 4309803.992% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 361460.911% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 2038.943% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -237352.868% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2322504.878% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1307.841% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -24094.791% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 2064.283% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -25.462% |
| AlloVir, Inc. | -398 Thousand USD | 478585.427% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -691.066% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -449044.34% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1570.33% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1586876.667% |
| ChromaDex Corporation | 50.78 Million USD | -3650.24% |
| Chimerix, Inc. | 324 Thousand USD | -587669.136% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 6210.09% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2554.151% |
| CRISPR Therapeutics AG | 240.95 Million USD | -690.34% |
| Precision BioSciences, Inc. | 40.47 Million USD | -4605.406% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 2040.01% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3191.743% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3191.743% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -11388.038% |
| ImmuCell Corporation | 4.39 Million USD | -43217.766% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1894.495% |
| Immix Biopharma, Inc. | -5468.00 USD | 34827678.639% |
| Incyte Corporation | 3.44 Billion USD | 44.651% |
| Innoviva, Inc. | 261.06 Million USD | -629.463% |
| IO Biotech, Inc. | -756 Thousand USD | 252001.058% |
| Jaguar Health, Inc. | 7.72 Million USD | -24555.256% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 286903.012% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1490.25% |
| ContextLogic Inc. | 59 Million USD | -3127.749% |
| MiMedx Group, Inc. | 266.84 Million USD | -613.668% |
| MEI Pharma, Inc. | 49.32 Million USD | -3760.709% |
| NextCure, Inc. | -3.68 Million USD | 51793.051% |
| Onconetix, Inc. | -1.12 Million USD | 169052.372% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 6674.054% |
| Opthea Limited | 21.72 Thousand USD | -8767726.888% |
| Psyence Biomedical Ltd. | -240.00 USD | 793488433.333% |
| Vaxcyte, Inc. | -75 Million USD | 2639.163% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3322103.977% |
| Precigen, Inc. | 106 Thousand USD | -1796477.358% |
| Pharming Group N.V. | 220.1 Million USD | -765.215% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -369680.971% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -188638.553% |
| PureTech Health plc | -1.6 Million USD | 118900.499% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1634.843% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1149.773% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 4301.593% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 8761.354% |
| Acelyrin, Inc. | -115 Thousand USD | 1656075.652% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 18947189.842% |
| Summit Therapeutics Inc. | -2.05 Million USD | 92996.195% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 333615.236% |
| Senti Biosciences, Inc. | -2.68 Million USD | 71079.202% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -46909.923% |
| Elevation Oncology, Inc. | -39 Thousand USD | 4883105.128% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 39790.955% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 48409.204% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -6437.718% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -383845.968% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3462594.545% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1729.385% |
| Seer, Inc. | 7.02 Million USD | -27000.783% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -43398.675% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -8739.044% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1607287.044% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1329031.41% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -312604.762% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1480.733% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -507.122% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 38087540.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -73884.926% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 3753296.689% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -6380.321% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 820950.0% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 387167.48% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 26929.699% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 401404.829% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 18311369.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -1956895.612% |
| Century Therapeutics, Inc. | -10.8 Million USD | 17718.392% |
| Kura Oncology, Inc. | -849 Thousand USD | 224407.656% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2937.941% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1295591.156% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1822.851% |
| Autolus Therapeutics plc | -4.86 Million USD | 39228.251% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -4501.488% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1133654.762% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1910.464% |
| GRI Bio, Inc. | 10.84 Million USD | -17466.387% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -74875.689% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 22022.09% |
| IGM Biosciences, Inc. | -211.66 Million USD | 999.732% |
| INmune Bio, Inc. | 155 Thousand USD | -1228527.097% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -2974.593% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 126527.895% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 293778.811% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 6505435.793% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -473624.378% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 95509.419% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 608525.559% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1916.04% |
| Verastem, Inc. | -62 Thousand USD | 3071667.742% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -78108.296% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 729744.444% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -62812.851% |
| Histogen Inc. | 3.76 Million USD | -50427.249% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -330417.426% |
| Surrozen, Inc. | -27.23 Million USD | 7093.654% |
| Organovo Holdings, Inc. | -5.38 Million USD | 35438.133% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 158154.91% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 7525.321% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -9397.167% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 96180504.04% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -31292.008% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 2836899.69% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1130.286% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1306053.635% |
| Apollomics, Inc. | 127 Thousand USD | -1499405.512% |
| Amarin Corporation plc | 165.54 Million USD | -1050.393% |
| Mesoblast Limited | -9.81 Million USD | 19502.669% |
| Turnstone Biologics Corp. | 16.5 Million USD | -11437.453% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1823.585% |
| Synaptogenix, Inc. | -6347.00 USD | 30004385.489% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 3734162.745% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1080.164% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -8.347% |
| Better Therapeutics, Inc. | -2.72 Million USD | 69882.778% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1797.891% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -463.289% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 16693402.945% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 30521.278% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 171974.729% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -25923.118% |
| Insmed Incorporated | 239.63 Million USD | -694.697% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -53124.483% |
| OmniAb, Inc. | 14.66 Million USD | -12884.059% |
| Alector, Inc. | -95.05 Million USD | 2103.484% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1415.966% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 4481.594% |
| Zai Lab Limited | 170.9 Million USD | -1014.3% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2225.894% |
| Aura Biosciences, Inc. | -1.29 Million USD | 147155.753% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1464801.538% |
| Immunic, Inc. | -111 Thousand USD | 1715750.45% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -11911.934% |
| Veracyte, Inc. | 248.14 Million USD | -667.434% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 127.248% |
| FibroGen, Inc. | 128.9 Million USD | -1377.357% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 337654709.929% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 16422.883% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 43.966% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -489455.784% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -435.922% |
| TG Therapeutics, Inc. | 219.1 Million USD | -769.148% |
| Galecto, Inc. | -830 Thousand USD | 229542.41% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 137599.783% |
| Fortrea Holdings Inc. | 424 Million USD | -349.144% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2310.094% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 335968.078% |
| XBiotech Inc. | -1.74 Million USD | 109295.642% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 171974.729% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 4197.979% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2621.212% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2494.406% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -11233.524% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -389.505% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 3935.825% |
| Vaxxinity, Inc. | -2.23 Million USD | 85344.942% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -482.821% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 16917.366% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -7688.524% |
| NexImmune, Inc. | -1.02 Million USD | 185897.466% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -35266048.148% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 26900.791% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 83.149% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 2849804.461% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 53729.175% |
| Ainos, Inc. | -253.73 Thousand USD | 750641.711% |
| Pluri Inc. | 322 Thousand USD | -591319.876% |
| Prothena Corporation plc | -129.2 Million USD | 1573.961% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -3676.722% |
| Celularity Inc. | 6.75 Million USD | -28092.036% |
| Rallybio Corporation | -150 Thousand USD | 1269681.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 5940.378% |
| MeiraGTx Holdings plc | 287 Thousand USD | -663444.251% |
| Omeros Corporation | -69.77 Million USD | 2829.148% |
| Humacyte, Inc. | -76.55 Million USD | 2587.749% |
| Immunocore Holdings plc | 248.39 Million USD | -666.683% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 12654.367% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -2952.759% |
| Blueprint Medicines Corporation | 236.58 Million USD | -704.945% |
| CalciMedica, Inc. | -58 Thousand USD | 3283500.0% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 133646.424% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -6454.369% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 67061.041% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 6270.005% |
| Pulmatrix, Inc. | -8.22 Million USD | 23267.543% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 162866.838% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 477386.216% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 577.533% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -68511.554% |
| Cytokinetics, Incorporated | -322.59 Million USD | 690.333% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -220797.918% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 558566.862% |
| Vor Biopharma Inc. | -3.49 Million USD | 54635.281% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1643.372% |
| Evogene Ltd. | 1.39 Million USD | -136023.803% |
| ProKidney Corp. | -3.16 Million USD | 60193.784% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4436.792% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -27672.67% |
| CorMedix Inc. | -205.56 Thousand USD | 926522.199% |
| BioLineRx Ltd. | 1.1 Million USD | -171774.729% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2520.679% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 5770924.242% |
| Atai Life Sciences N.V. | -5000.00 USD | 38087540.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1562866.804% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1983820.833% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 137203.816% |
| Sagimet Biosciences Inc. | 2 Million USD | -95118.6% |
| MediciNova, Inc. | 979.7 Thousand USD | -194282.186% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2358.532% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2014136.275% |
| GeoVax Labs, Inc. | -20.72 Million USD | 9290.645% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -678.773% |
| Biomea Fusion, Inc. | -4.2 Million USD | 45431.397% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -118.307% |
| Mereo BioPharma Group plc | 7.42 Million USD | -25544.654% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 614413.548% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 15869866.667% |
| Absci Corporation | -41.84 Million USD | 4650.579% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 38087540.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2593.515% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 77482.04% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -790.997% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 202477.471% |
| Allakos Inc. | -6.14 Million USD | 31110.78% |
| Imunon, Inc. | -720 Thousand USD | 264594.274% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 2860.119% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -300.167% |
| BioAtla, Inc. | -103.73 Million USD | 1935.875% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 16693402.945% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1069971.91% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 884.276% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 612438.264% |
| XOMA Corporation | 3.86 Million USD | -49223.284% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 2817.232% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -12772.597% |
| aTyr Pharma, Inc. | -2.38 Million USD | 79847.571% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -15183.884% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 6566900.0% |
| Viridian Therapeutics, Inc. | -1 Million USD | 189025.794% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -14649015284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 47609400.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -199.01% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -977965.616% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2496.21% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 7234.083% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -16402759.604% |
| Orgenesis Inc. | -5.72 Million USD | 33364.14% |
| Entera Bio Ltd. | -56 Thousand USD | 3400764.286% |
| GH Research PLC | -315 Thousand USD | 604662.54% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1007704.233% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 362837.524% |
| Xencor, Inc. | -85.26 Million USD | 2333.605% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 861896.477% |
| Replimune Group, Inc. | -2.65 Million USD | 71827.759% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 190302.11% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -970.81% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -977965.616% |
| Portage Biotech Inc. | -54 Thousand USD | 3526714.815% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2014136.275% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 505238.462% |
| OncoCyte Corporation | 413 Thousand USD | -461007.022% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 42366551.613% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 857825325.225% |
| Purple Biotech Ltd. | -196 Thousand USD | 971718.367% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -21135.192% |
| scPharmaceuticals Inc. | 9.78 Million USD | -19368.125% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 18332.454% |
| HilleVax, Inc. | -2.15 Million USD | 88428.942% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1963370.103% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 12692528.686% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 285185.629% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 8279978.261% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 25370888.792% |
| Savara Inc. | -44.26 Million USD | 4402.499% |
| Curis, Inc. | 9.81 Million USD | -19310.58% |
| Daré Bioscience, Inc. | 2.76 Million USD | -68661.757% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1526185.842% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 110242.973% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 835350.877% |
| BeiGene, Ltd. | 2.07 Billion USD | 8.393% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 68213.023% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 576.493% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3259.392% |
| Erasca, Inc. | -3.73 Million USD | 51128.189% |
| bluebird bio, Inc. | -4.03 Million USD | 47354.888% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6748884.464% |
| DBV Technologies S.A. | 15.72 Million USD | -12008.164% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 6748884.464% |
| Moderna, Inc. | 2.15 Billion USD | 11.63% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 208228.087% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -23686.81% |
| Molecular Templates, Inc. | 50.39 Million USD | -3678.891% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 355393.284% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1323.425% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 30707.072% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 4940.434% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1813.674% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 53176.143% |
| MacroGenics, Inc. | 50.52 Million USD | -3669.019% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 31329.452% |
| Prime Medicine, Inc. | -147.9 Million USD | 1387.564% |
| Aditxt, Inc. | -111.66 Thousand USD | 1705609.583% |
| Adagene Inc. | 18.11 Million USD | -10414.717% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -390140.164% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1258.306% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1106.551% |
| SciSparc Ltd. | 2.19 Million USD | -86620.036% |
| Vericel Corporation | 135.57 Million USD | -1304.653% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7602686.93% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 6146804.538% |
| Generation Bio Co. | -73.91 Million USD | 2676.575% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 435883.066% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3386.648% |
| Invivyd, Inc. | -2.02 Million USD | 94003.945% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 733.016% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1841175.814% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1876.146% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1837.543% |
| ADMA Biologics, Inc. | 88.21 Million USD | -2058.711% |
| Clene Inc. | 533 Thousand USD | -357193.058% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -7798.948% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 199093.939% |
| GeoVax Labs, Inc. | -20.72 Million USD | 9290.645% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -95693.36% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 980138.7% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -3723.656% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 26952.397% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 227895.694% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2183.009% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2604632.465% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3482.205% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1199.598% |
| Trevena, Inc. | 1.45 Million USD | -130784.674% |
| Surrozen, Inc. | -27.23 Million USD | 7093.654% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 539582.153% |
| Cingulate Inc. | -582.91 Thousand USD | 326796.379% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 6143235.484% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 9767.354% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 25156929.59% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 216260.272% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -179.764% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 192850.202% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3380122.008% |
| Kronos Bio, Inc. | 1.37 Million USD | -138702.624% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 3648.563% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 652282.192% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 390089.228% |
| ImmunityBio, Inc. | -17.89 Million USD | 10744.897% |
| Korro Bio, Inc. | -3.63 Million USD | 52562.039% |
| Kineta, Inc. | 5.43 Million USD | -34951.942% |
| BioVie Inc. | -229.37 Thousand USD | 830336.685% |
| Codexis, Inc. | 57.33 Million USD | -3221.54% |
| Celularity Inc. | 6.75 Million USD | -28092.036% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -47355.071% |
| Celcuity Inc. | -142.77 Thousand USD | 1333955.378% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -3764224.965% |
| Cibus, Inc. | 1.42 Million USD | -133822.082% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 509290.374% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 8409.141% |
| IN8bio, Inc. | -2.5 Million USD | 76244.422% |
| Kodiak Sciences Inc. | -25.94 Million USD | 7439.469% |
| Annexon, Inc. | -3.26 Million USD | 58391.154% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 93268.885% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 4662.791% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -297458.125% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -144.616% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1001.079% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 100330.105% |
| Arcellx, Inc. | 108.27 Million USD | -1658.764% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 5983.32% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2304.389% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 9103.272% |
| Moolec Science SA | -143.3 Thousand USD | 1328994.316% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 4600.147% |
| Geron Corporation | -123.5 Million USD | 1641.964% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -57836.477% |
| Royalty Pharma plc | 1.79 Billion USD | -6.158% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 2817.038% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 52723577.298% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -822910.402% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1809.275% |
| Humacyte, Inc. | -76.55 Million USD | 2587.749% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 200734.657% |
| 89bio, Inc. | -273 Thousand USD | 697672.161% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 151601.352% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 224672.17% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1548369.919% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -170085.165% |
| Notable Labs, Ltd. | 113 Thousand USD | -1685184.956% |
| Liquidia Corporation | 14.6 Million USD | -12943.644% |
| Mustang Bio, Inc. | -2.22 Million USD | 85689.753% |
| Immunovant, Inc. | -231 Thousand USD | 824503.463% |
| Quantum-Si incorporated | 488 Thousand USD | -390140.164% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3527.657% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 6348006.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -102175.618% |
| Acasti Pharma Inc. | -11 Thousand USD | 17312572.727% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 930800.773% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 293778.811% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1236.857% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -167748.191% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 499935.171% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 97361.083% |
| PepGen Inc. | -1.18 Million USD | 160942.23% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1499605.512% |
| United Therapeutics Corporation | 2.07 Billion USD | 8.001% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 8417.125% |
| Solid Biosciences Inc. | -76.56 Million USD | 2587.327% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2306109.711% |
| Immuneering Corporation | -764.13 Thousand USD | 249318.335% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -2873816.455% |
| Belite Bio, Inc | -399 Thousand USD | 477386.216% |
| XOMA Corporation | 3.86 Million USD | -49223.284% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 9604.751% |
| Bionomics Limited | -434.44 Thousand USD | 438441.9% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 177415.829% |
| uniQure N.V. | 2.21 Million USD | -85876.163% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2229.622% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2168.418% |
| Forte Biosciences, Inc. | -9000.00 USD | 21159788.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 228168.503% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 435883.066% |
| Altimmune, Inc. | -65.37 Million USD | 3013.086% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -426.026% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 177415.829% |
| Compugen Ltd. | 31.45 Million USD | -5954.274% |
| Peak Bio, Inc. | 367.76 Thousand USD | -517717.434% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -7667.874% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1763207.407% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2441602.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 158401.912% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 104620.966% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1600412.605% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 158401.912% |
| Instil Bio, Inc. | -4.75 Million USD | 40141.463% |
| argenx SE | 1.1 Billion USD | -71.8% |
| Immunome, Inc. | -8.9 Million USD | 21480.622% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 100860.423% |
| Verona Pharma plc | -679.62 Thousand USD | 280309.645% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1088312.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 79947.883% |
| CervoMed Inc. | -1.29 Million USD | 147311.832% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 79218.072% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 39965.439% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -76968.879% |
| Moolec Science SA | -143.3 Thousand USD | 1328994.316% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 466823.525% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 71383.999% |
| AnaptysBio, Inc. | 14.78 Million USD | -12783.919% |
| Design Therapeutics, Inc. | -537 Thousand USD | 354731.657% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 446088.759% |
| NeurAxis, Inc. | 2.15 Million USD | -88200.11% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -88640.541% |
| Lumos Pharma, Inc. | 2 Million USD | -94786.497% |
| Achilles Therapeutics plc | -4.73 Million USD | 40350.783% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1088312.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1802202.673% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -5915.31% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -220797.918% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 184632.171% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 4281.022% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -4428672.093% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 231775.426% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 14473211.415% |
| Palisade Bio, Inc. | 246 Thousand USD | -774034.959% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 5770924.242% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3291.4% |
| Neurogene Inc. | -3.26 Million USD | 58480.503% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1266.758% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 51681.04% |
| Sesen Bio, Inc. | 40 Million USD | -4660.93% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 641302.694% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 47389.657% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 20007.715% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -13425.369% |
| Athira Pharma, Inc. | -969 Thousand USD | 196629.618% |
| Vaccinex, Inc. | -16 Million USD | 11999.35% |
| HCW Biologics Inc. | -574.82 Thousand USD | 331396.536% |
| XOMA Corporation | 3.86 Million USD | -49223.284% |
| Nektar Therapeutics | 53.47 Million USD | -3461.038% |
| Arvinas, Inc. | 71.8 Million USD | -2552.329% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 2381.75% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 3133.647% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 591519.876% |
| Rezolute, Inc. | -36 Thousand USD | 5290022.222% |
| Clene Inc. | 533 Thousand USD | -357193.058% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 148315676.324% |
| BeyondSpring Inc. | 1.75 Million USD | -108659.109% |
| Synlogic, Inc. | -1.92 Million USD | 99079.834% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 5147051.351% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 30175.363% |
| Peak Bio, Inc. | 367.76 Thousand USD | -517717.434% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 10142.567% |
| Krystal Biotech, Inc. | 47.6 Million USD | -3900.361% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1249.747% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -37797.95% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 73650.055% |
| MannKind Corporation | 136.19 Million USD | -1298.31% |
| Ikena Oncology, Inc. | -50.49 Million USD | 3871.631% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1650.117% |
| Gossamer Bio, Inc. | -4.38 Million USD | 43529.236% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 755803.175% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 38087540.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1251.299% |
| Mural Oncology plc | -2.56 Million USD | 74286.677% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 345721.053% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1904472.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -9075.928% |
| REGENXBIO Inc. | 53.02 Million USD | -3491.19% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 35649.537% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 990026.966% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 110052.194% |
| Vaxart, Inc. | -60.76 Million USD | 3234.098% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 724802.032% |
| Cellectis S.A. | 18 Thousand USD | -10579744.444% |
| Longeveron Inc. | 221 Thousand USD | -861606.787% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2478.384% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -74.235% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 147269.397% |
| Revolution Medicines, Inc. | -399.66 Million USD | 576.493% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 5441162.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -3886373.469% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 77.874% |
| Denali Therapeutics Inc. | -93.34 Million USD | 2140.144% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 7602686.93% |
| Veru Inc. | 7.56 Million USD | -25070.369% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1261273.51% |
| Cingulate Inc. | -582.91 Thousand USD | 326796.379% |
| Passage Bio, Inc. | -3.72 Million USD | 51279.038% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 15811890.103% |
| Exicure, Inc. | -1.42 Million USD | 133927.969% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 497325.065% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -70354.014% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 371557.941% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2695.367% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1273016.374% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3316.519% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -486951.662% |
| OmniAb, Inc. | 14.66 Million USD | -12884.059% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -9425.194% |
| Lipocine Inc. | -2.85 Million USD | 66900.897% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 103430.005% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 33480.754% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 126527.895% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2428.509% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 2929903.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -2159.149% |
| Ocugen, Inc. | -33.53 Million USD | 5778.421% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 60326.818% |
| Q32 Bio Inc. | 578 Thousand USD | -329376.125% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 718730.943% |
| Alumis Inc. Common Stock | -1.28 Million USD | 148415.576% |
| Equillium, Inc. | 35.95 Million USD | -5196.101% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 111662.507% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -380257.874% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 46066186.115% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 735378.764% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -450412.879% |
| Dominari Holdings Inc. | 2.03 Million USD | -93297.352% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1038068.943% |
| vTv Therapeutics Inc. | -13.59 Million USD | 14107.885% |
| Bio-Techne Corporation | 773.07 Million USD | -146.338% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -10895.854% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -313.288% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 163006.074% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 8041.501% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -16180.858% |
| Nkarta, Inc. | -5.86 Million USD | 32547.981% |
| BioCardia, Inc. | -7.24 Million USD | 26370.824% |
| Iterum Therapeutics plc | -1.75 Million USD | 108921.257% |